url: https://news.google.com/rss/articles/CBMiigFBVV95cUxQTDB2Rnl5VU05YmpnOUQ4SXRPM3RCUHdVaml1UTctdjhGS0w3MHdJX1lMempyYmNVUl9NNW5HemZoNDlzWE5wbjlaVEFHSDl1a0I0dnRNeFRzQzREM1FDZWhPSjJBWU5ZVThxRmFVMnRLYUJYX3F5cHVkOEtIVXNWakRmYnpISS1EQ1E?oc=5 · headline: Nvidia-backed Iambic files for IPO, disclosing new clinic and dealmaking details · publication: Endpoints News
google_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMihwFBVV95cUxOaS04TC05cUprajFTWmdKQjBHZE1ycXh5Ql9wMURJV1hlVDFKaGZJdkw4a0U3RVY2eXJFbjlfeHNQVnY1UkxiNUY2RDQtZlpzeFM4NGZHNzN5ak5XblBNdDNudlRzSGZHaHJGRDFXcFp0Qno4MkJERS1rVkhNSS1DR2F4TXlwWGM?oc=5 · headline: AI drug hunter Iambic files for Nasdaq IPO · publication: BioXconomygoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMijgJBVV95cUxOclVuNno3RmpLNFhwdjJmZE5aNi12UnEzc3B5eDN3RmtmZlhoelBmUHRLdDhiNFlfOFlOQ3dwcHE2MFgteFRKaThXMFl6LVlaVDllZUhvVTBaU1BhUEJoT1lINl9FUHNmYXNLV1dDWXdZb2FYaWd4aS1FN3NTY3R1NF82M19EQlF5VDlMYjlUdHFTaWZyM0Q3WFNwUm5XZGtjUERIOW9uU1o1dXlKTlV2Q21GbFMzbkd2WnEtekdvbGRCSDUyQ21saHdjMzRhejJVNXhpLWhOZC1PU0lMQWlydmNSMG5VcmVzdkJnUzlsZlJXQjZzUUYyN3pDQTI1dVNnZG9PUGVIVUtaNDE0T1E?oc=5 · headline: Iambic Submits IND for a Potentially Brain-Penetrant KIF18A Inhibitor IAM217, Its Second Wholly Owned AI-Discovered Candidate · publication: Business Wiregoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMitAFBVV95cUxNT2hjb1lXWXBJVzIzR0djYnVNMXE2QjBZTmNYa3Q2aXlXNkNVVUNIVUZNYmRKU3V4dk9ReFdMUXNETVJMVnhHMGxUSzUwWjVqNnpXUnkzYXk3YlhSTjhxWHcxZ25SdUEzRUlFaFZPVm5YZjl4bm9wMThqNGVGOW1UdE9IOXlWN1cwVGpkdTNwZ2JYdUZJYmJPWkRxQjdwbGxlTFRKc0JYbWNkc25xUGNaUkpsNS0?oc=5 · headline: Iambic files IND for IAM217, its second wholly owned AI-designed cancer candidate · publication: Dealroomgoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMiU0FVX3lxTE5DSmVBTXljZk5sNlY2R2pNVm9ta2hjUXNvTU01cjdRTXo3VXA3OFpmNkxVRTl3Rm1DaTN2R1pXRXo1dW5CTjBWZzlrQ1o0SGJXS3VF?oc=5 · headline: AbbVie signs on to Iambic’s new AI drug discovery model · publication: FirstWord Pharmagoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMisgFBVV95cUxPRGEzYlYySFRiUHdVcXpDc0lQdEt3VEZvLXE2azRncWtZUkNYVWNmX3BZaXM2akdtMGx4bWRockhldDBGNllkWGt3TUo5aHVDRGhRSzR4VmFOY09QalhVNExEdFRFMmpfVXlvN1ZvNTd0NWtETnF3TVVFYS1wbVd6Y1B5NUFCMFh0cFRMZVlqeVo1SW13OHMwVk9VT3h5V1Q0dmtwclNLdnRpUXE4c041T3FB?oc=5 · headline: Iambic Therapeutics prices IPO at $16 per share to raise $150 million · publication: scanx.tradegoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMipAFBVV95cUxOQ3dnT09ITFZRNjA3MXpIWDZrNGF1MzRnNGxkWXVjYUhuNFRpUXIyeUJnc1Q2YllBOW0tSTNrWjBqN083VlRmNmhZQmxlREFJRDlOZkU0UmRGcFYyLVF3eUVCN3FBd3JvaUhyNTFOdG1iZ2VBN2ZyOEdRRS10WWRsWTcwRDc4UWtIdzJYcXlVNnNKc0F5ZUczemc5ZnAyblgxNHlWYw?oc=5 · headline: Iambic aims for $135M IPO to push cancer drugs through clinic · publication: Fierce Biotechgoogle_news · 10/15/2026